Drug Shortage Report for DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML

Last updated on 2021-01-27 History
Report ID 131489
Drug Identification Number 00585092
Brand name DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML
Common or Proper name DEPO-PROVERA
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) MEDROXYPROGESTERONE ACETATE
Strength(s) 150MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 x 1ML
ATC code G03AC
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-07-01
Actual start date
Estimated end date 2022-06-01
Actual end date
Shortage status Anticipated shortage
Updated date 2021-01-27
Company comments Available inventory is currently on preventative allocation.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-01-12 English Compare
v2 2021-01-12 French Compare
v3 2021-01-13 English Compare
v4 2021-01-26 English Compare
v5 2021-01-26 French Compare
v6 2021-01-27 English Compare
v7 2021-01-27 French Compare